Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 11/2012

01-11-2012 | Erratum

Erratum to: Implementing patient-centred cancer care: using experience-based co-design to improve patient experience in breast and lung cancer services

Authors: Vicki Tsianakas, Glenn Robert, Jill Maben, Alison Richardson, Catherine Dale, Mairead Griffin, Theresa Wiseman

Published in: Supportive Care in Cancer | Issue 11/2012

Login to get access

Excerpt

Erratum to: Support Care in Cancer …
Metadata
Title
Erratum to: Implementing patient-centred cancer care: using experience-based co-design to improve patient experience in breast and lung cancer services
Authors
Vicki Tsianakas
Glenn Robert
Jill Maben
Alison Richardson
Catherine Dale
Mairead Griffin
Theresa Wiseman
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 11/2012
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1567-8

Other articles of this Issue 11/2012

Supportive Care in Cancer 11/2012 Go to the issue

Original Article

Impact of oxaliplatin-induced neuropathy: a patient perspective

Original Article

Advance directives: prevalence and attitudes of cancer patients receiving radiotherapy

Original Article

Ixabepilone-associated peripheral neuropathy: data from across the phase II and III clinical trials

Original Article

Testicular cancer survivors' supportive care needs and use of online support: a cross-sectional survey

Original Article

Prospective observational Italian study on palliative sedation in two hospice settings: differences in casemixes and clinical care

Original Article

Identification of a novel marker associated with risk for delayed chemotherapy-induced vomiting
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits